[PRESS RELEASE – Zug, Switzerland, December 4th, 2025] Ika, the fastest parallel MPC network, today announced a mainnet upgrade that enables EdDSA signatures directly from dWallets, significantly expanding Ika’s native cross-chain coverage to include Solana, Zcash, Cardano, Stellar, Near, and other EdDSA-based ecosystems. This upgrade extends Ika’s core promise: natively control accounts and assets across […][PRESS RELEASE – Zug, Switzerland, December 4th, 2025] Ika, the fastest parallel MPC network, today announced a mainnet upgrade that enables EdDSA signatures directly from dWallets, significantly expanding Ika’s native cross-chain coverage to include Solana, Zcash, Cardano, Stellar, Near, and other EdDSA-based ecosystems. This upgrade extends Ika’s core promise: natively control accounts and assets across […]

Ika Announces EdDSA Signatures, Expanding Native Support to Solana, Zcash, Cardano and More

[PRESS RELEASE – Zug, Switzerland, December 4th, 2025]

Ika, the fastest parallel MPC network, today announced a mainnet upgrade that enables EdDSA signatures directly from dWallets, significantly expanding Ika’s native cross-chain coverage to include Solana, Zcash, Cardano, Stellar, Near, and other EdDSA-based ecosystems.

This upgrade extends Ika’s core promise: natively control accounts and assets across chains without bridges, wrapping, custodians, or trusted signers, now across a broader set of networks where EdDSA is the standard.

What This Upgrade Enables

Until now, Ika’s dWallets provided zero-trust signing and programmable control for major ecosystems, including Bitcoin and EVM-compatible networks with ECDSA signatures. With EdDSA enabled at the dWallet signing layer, builders can now create applications that:

  • Control Solana accounts natively, enabling cross-chain trading, vaults, payments, and automation without wrapped assets.
  • Coordinate Zcash-native actions under programmable dWallet policies, unlocking zero-trust custody and interoperability for the most prominent privacy-preserving cryptocurrency.
  • Manage Cardano, Stellar, Near accounts with smart contract-governed access control, enabling organizational treasury workflows and institutional-grade policy enforcement.

In short: dWallets become natively multi-ecosystem signers, and enable a coordination layer for policy, composability, and execution logic.

Native Cross-Chain Control

Most cross-chain systems rely on bridges, message relays, wrappers, or trusted intermediaries. These approaches introduce risk (custody, exploits, governance capture) and limit composability.

Ika’s model is different: no bridging of assets is required. Instead, Ika enables native signing via dWallets, where transaction authorization is always enforced under zero-trust assumptions.

With EdDSA enabled, the same architecture now extends to chains where ECDSA is not supported and EdDSA has been adopted instead, dramatically expanding the surface area of what Ika dWallets can safely and directly orchestrate.

How EdDSA Works in Ika’s Zero-Trust Model

Ika’s security model is built on its 2PC-MPC cryptographic scheme.

dWallet signing splits authorization into two independent components:

  • User share: held and authorized locally by the user
  • Network share: operated by Ika’s decentralized network of MPC nodes

Both are required to produce a valid signature, and the full private key is never reconstructed. With this mainnet upgrade, that same model now supports EdDSA signing, bringing the benefits of Ika’s architecture (zero-trust, decentralization, scalability, sub-second performance, and programmable policy enforcement) to a wider set of chains.

Why It Matters for Builders and the Ecosystem

This upgrade expands the design space for applications that are only possible with Ika, including:

Universal accounts across ecosystems

One programmable signing primitive that can operate across EdDSA and non-EdDSA chains, operated with the same SDK and smart contract.

Cross-chain DeFi with native assets

Strategies can coordinate multiple ecosystems while keeping assets on their home chains. No wrapping, no “bridged liquidity.”

Programmable custody and access control

Rules are enforced at the signing layer: multi-party approvals, intent constraints, spending limits, automated risk controls, and organizational policy, secured cryptographically rather than contract-side permissions alone.

Chain abstraction that’s actually zero-trust

Users don’t “rent” their wallet to an app or provider. They co-authorize with the network under strict cryptographic guarantees.

Availability

The EdDSA-enabled signing upgrade is live on Ika mainnet, and supports dWallet-based signing for Solana, Zcash, Cardano, Stellar, Near, and additional EdDSA-compatible chains.

Developers can begin integrating EdDSA-enabled dWallet workflows immediately through Ika’s developer resources.

About Ika

Ika is the fastest parallel MPC network, offering sub-second latency, unprecedented scale and decentralization, and zero-trust security. As the premier choice for interoperability, decentralized custody, and chain abstraction, Ika is set to revolutionize digital asset security and multi-chain DeFi. Users can learn more here.

The post Ika Announces EdDSA Signatures, Expanding Native Support to Solana, Zcash, Cardano and More appeared first on CryptoPotato.

Market Opportunity
Ika Logo
Ika Price(IKA)
$0.005876
$0.005876$0.005876
-7.34%
USD
Ika (IKA) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26